1) BrdU incorporation assays
5-溴脱氧尿苷掺入法
2) BudR incorporation trial
溴脱氧尿嘧啶核苷掺入法
3) 5-bromodeoxyuridine
5-溴脱氧尿核苷
1.
In this study, we employed LiCl-pilocarpine-induced temporal lobe epilepsy rat model, used 5-bromodeoxyuridine (BrdU) to label newborn cells, and sought to examine the effects of lamotrigine on the neurogenesis in the SGZ after seizures induced by lithium-pilocarpine.
为此,本课题采用锂-匹罗卡品诱发大鼠颞叶癫癎模型,利用5-溴脱氧尿核苷(BrdU)标记分裂细胞,通过免疫组织化学方法观察LTG对成年癫癎大鼠海马神经前体细胞增殖、存活、分化以及迁移的影响,以期为临床应用LTG提供更多的实验依据。
4) bromodeoxyuridine
['brəuməudi,ɔksi'juəridi:n]
5-溴脱氧尿苷
5) BrdU incorporation
溴代脱氧尿(嘧啶核)苷掺入
6) BrdU
5-溴脱氧尿嘧啶核苷
1.
Technical explore on mesenchymal stem cells in bone marrow using BrdU labelling;
5-溴脱氧尿嘧啶核苷标记骨髓间充质干细胞的技术探讨
2.
Objective To study the feasibility of labeling adipose-derived adult stem cells with BrdU.
目的探讨5-溴脱氧尿嘧啶核苷(BrdU)标记脂肪成体干细胞(adipose-derived adult stem cells,ADASCs)的可行性。
3.
AIM: To study the differentiation characteristics and the optimal dosage and timing for bromodeoxyuridine (Brdu) labeling of rat bone marrow-derived mesenchymal stem cells (MSCs) in vitro.
目的:探讨骨髓间充质干细胞(MSCs)在体外的诱导分化及5-溴脱氧尿嘧啶核苷(Brdu)标记MSCs的可行性。
补充资料：2'-溴-2'-脱氧-3', 5'-双乙酰基-5'-甲基尿苷
分子式：C14H17BrN2O7
分子量：405.00
CAS号：暂无
性质：该品为类白或微黄结晶粉末。
制备方法：暂无
用途：暂无
分子量：405.00
CAS号：暂无
性质：该品为类白或微黄结晶粉末。
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条